Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-162-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
LD50 oral rat is > 200 and < 2000 mg/kg bw
LD 50 dermal rat is > 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- of 22th March 1996
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Age at study initiation: 8-10 weeks
- Weight at study initiation: 173 g (mean females) and 204 g (mean males)
- Housing: 3 animals per cage
- Diet (e.g. ad libitum): yes
- Water (e.g. ad libitum): yes
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 °C
- Humidity (%): 55 ± 5 °C
- Air changes (per hr): 15 - 20 per hour
- Photoperiod (hrs dark / hrs light): 12 h rhythm
IN-LIFE DATES: From: To: 10 SEPT 1997 to 08 OKT 1997 - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on oral exposure:
- application volume 10 mL/kg bw
The test substance was formulated in the application vehicle immediately prior to teatment. Therefore analytical investigations of the stability in the vehicle were not performed. - Doses:
- 2000 mg/kg bw as first dose in males; 200 mg/kg bw as second dose in male and females
- No. of animals per sex per dose:
- 3 males and 6 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: several times on the day of administration, and at least once daily during the following 14 day observation period
- body weights: weekly
- Necropsy of survivors performed: yes
- Statistics:
- not applicable
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 200 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: LD50 between 200 and 2000 mg/kg bw
- Mortality:
- all 3 female rats died after administration of 2000 mg/kg bw within 1 hour
- Clinical signs:
- other: No clinical signs
- Gross pathology:
- Severe red discoloration of the stomach and small intestine was observed at necropsy in the intercurrent death animals (2000 mg/kg bw group). None of the sacrificed animals showed any noticable gross pathological findings (200 mg/kg bw group).
- Interpretation of results:
- Category 4 based on GHS criteria
- Executive summary:
The acute oral LD50 in rats was determined as > 200 mg/kg bw and < 2000 mg/kg bw based on the results of a limit dose study performed according to OECD TG 423. The test dose of 2000 mg/kg led to mortality of 3/3 females with severe red discoloration of the stomach and small intestine at necropsy. The second dose of 200 mg/kg bw tested in 3 male and 3 female rats was well tolerated without clinical signs or any noticeable gross pathological findings. Since the dose of 200 mg/kg bw turned out as the NOEL for both sexes it can be considered that the LD50 is > 300 mg/kg bw (Acute Tox 4), as shown in the flow chart in Annex 3c of OECD 423 (1996) and Annex 2d of OECD 423 (2001). The test substance should thus be regarded as harmful if swallowed.
Reference
Dose (mg/kg bw) | sex | toxicological result | mortality | onset of mortality |
(1st) 2000 | female | 3 / 3 | 100 % | 1h |
(2nd) 200 | female | 3 / 0 | --- | --- |
(2nd) 200 | male | 3 / 0 | --- | --- |
Toxicological results:
number of dead animals / number of animals treated
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- (1987)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: HsdCpb: Wu
- Source: Harlan Winkelmann GmbH, Borchen, Germany
- Age at study initiation: approximately 9 weeks for males, about 12 weeks for females
- Weight at study initiation: males 237-251 g; females 196-207 g
- Housing: The animals were caged individually in polycarbonate cages on low dust wood granulate bedding.
- Diet and water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): 55 +/- 5
- Air changes (per hr): approx. 10
- Photoperiod (hrs dark / hrs light): 12 / 12 - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
One day before the start of the treatment the back and flanks of the rats were shorn. For each dose and animal the required amount of the solid test substance was weighed out and applied to a wet gauze-layer (6.0 cm x 5.0 cm = 30.0 cm²) of a "Cutiplast steril" coated with air-tight "Leukoflex". The gauze strip was placed on the rat's back and secured with a "Lomir biomedical Inc rat jacket", which was connected with a safety pin to the stretch tape to ensure that the animals could not ingest the test substance.
REMOVAL OF TEST SUBSTANCE
After approximately 24 hours the dressings were removed and the area was rinsed with water and soap and gently patting the area dry. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw per 30.0 cm²
Dose range: males 30.1 - 31.9 mg/cm²; females 28.0 - 29.6 mg/cm². - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: at least 14 days
- Frequency of observations and weighing: Clinical signs and mortality rates were determined several times on the day of application and subsequently at least once daily. The weight gain of the animals was checked weekly until the end of the study.
- Necropsy of survivors performed: yes - Statistics:
- An assessment of the LD50 was made based on the applied dose and a software program according to Spearman and Kärber, if appropriate.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortalities occurred.
- Clinical signs:
- other: No clinical signs were observed.
- Gross pathology:
- The necropsies performed at the end of the study revealed no particular findings.
- Other findings:
- one male showed local skin effects (treatment area was partly encrusted on day 11 of the study).
- Interpretation of results:
- GHS criteria not met
- Executive summary:
An acute dermal toxicity study was performed according to OECD TG 402. For the purpose of a limit test 2000 mg/kg of the test item was applied occlusively to the skin of 5 male and 5 female rats for 24 hours. No mortalities, no clinical signs, no effects on weight development and no gross pathological findings were observed during the 14-days observation period. One male showed local skin effects (treatment area was partly encrusted) on day 11 of the study only. The resulting LD50 was thus determined with > 2000 mg/kg bw for both sexes combined.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Additional information
The acute oral LD50 in rats was determined as > 200 mg/kg bw and < 2000 mg/kg bw based on the results of a limit dose study performed according to OECD TG 423. The test dose of 2000 mg/kg led to mortality of 3/3 females with severe red discoloration of the stomach and small intestine at necropsy. The second dose of 200 mg/kg bw tested in 3 male and 3 female rats was well tolerated without clinical signs or any noticeable gross pathological findings. The test substance should be regarded as harmful if swallowed.
An acute dermal toxicity study was performed according to OECD TG 402. For the purpose of a limit test 2000 mg/kg of the test item was applied occlusively to the skin of 5 male and 5 female rats for 24 hours. No mortalities, no clinical signs, no effects on weight development and no gross pathological findings were observed during the 14-days observation period. One male showed local skin effects (treatment area was partly encrusted) on day 11 of the study only. The resulting LD50 was thus determined with > 2000 mg/kg bw for both sexes combined.
Justification for classification or non-classification
In an LD50 study on rats following OECD TG 423 of 1996 the oral dose of 2000 mg/kg bw led to death of all 3 treated females. The second dose of 200 mg/kg bw tested in 3 males and 3 females was well tolerated. Since the dose of 200 mg/kg bw turned out as the NOEL for both sexes it can be considered that the LD50 is > 300 mg/kg bw (Acute Tox 4), as shown in the flow chart in Annex 3c of OECD 423 (1996) and Annex 2d of OECD 423 (2001). According to Regulation 1272/2008 the test substance should thus be regarded as harmful if swallowed (Acute Tox 4, H302).
No classification for acute dermal toxicity is warranted since the dermal LD50 was determined with > 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
